首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Incidence, predictors, and outcome of reinfarction and stent thrombosis within one year after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
【24h】

Incidence, predictors, and outcome of reinfarction and stent thrombosis within one year after primary percutaneous coronary intervention for ST-elevation myocardial infarction.

机译:在ST抬高型心肌梗死的首次经皮冠状动脉介入治疗后一年内,再梗死和支架血栓形成的发生率,预测因素和结果。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Reinfarction and stent thrombosis are major complications after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI). OBJECTIVE: We sought to investigate the incidence, predictors, and outcome of reinfarction and stent thrombosis in a contemporary cohort of STEMI patients. METHODS: Reinfarction and stent thrombosis within 1 year after primary PCI for STEMI were analyzed in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS). RESULTS: Reinfarction was observed in 3.4% (34/995) of patients within 1 year after primary PCI. Angiographic evidence of stent thrombosis was observed in 15/34 (44.1%). During the index primary PCI, intra-aortic balloon counterpulsation was used in 10/32 (31.3%) patients with and 47/900 (5.2%) without reinfarction (P < 0.001). After the index primary PCI, thrombus was visible in 6/34 (17.7%) with reinfarction when compared with that in 25/952 (2.6%) without reinfarction (P < 0.001), and complete ST-segment resolution in 8/33 (24.2%) compared with that in 462/892 (51.8%, P = 0.002). Mortality at 1 year after the index PCI was higher after reinfarction: 6/34 (17.7%) compared with 53/961 (5.5%, P = 0.003). Patients with stent thrombosis showed myocardial blush grade 0-1 in 11/15 (73.3%) cases, distal embolization in 8/15 (53.3%), and a mortality at 1 year of 4/15 (26.7%). CONCLUSIONS: In contemporary practice with primary PCI and triple antiplatelet therapy for STEMI, the incidence of reinfarction is low. Outcome characteristics after the index PCI were important determinants of reinfarction. However, reinfarction was associated with poor prognosis, and in particular patients with stent thrombosis had poor outcome.
机译:背景:对于ST段抬高型心肌梗死(STEMI),经皮冠状动脉介入治疗(PCI)后,再梗塞和支架血栓形成是主要并发症。目的:我们试图调查当代STEMI患者队列中再梗塞和支架血栓形成的发生率,预测因素和结果。方法:在急性心肌梗死研究(TAPAS)中,经皮冠状动脉介入治疗期间的血栓抽吸分析了STEMI初次PCI后1年内的再梗塞和支架血栓形成情况。结果:在初次PCI后1年内,有3.4%(34/995)的患者发生了再梗塞。在15/34(44.1%)观察到支架血栓形成的血管造影证据。在初发PCI期间,有10/32(31.3%)的患者在没有再梗塞的情况下使用了主动脉内球囊反搏;在没有梗塞的情况下,有47/900(5.2%)的患者使用了主动脉内球囊反搏(P <0.001)。初次PCI后,有再梗塞的血栓在6/34可见(17.7%),而没有再梗塞的25/952(2.6%)可见(P <0.001),在8/33有完全ST段分辨率( 2462%),而462/892(51.8%,P = 0.002)。梗死后PCI指数1年后的死亡率较高:6/34(17.7%),而53/961(5.5%,P = 0.003)。支架内血栓形成的患者在11/15(73.3%)的病例中显示为0-1级心肌红晕(73.3%),在8/15的患者中远端栓塞(53.3%),在1年时的死亡率为4/15(26.7%)。结论:在当代治疗STEMI的原发性PCI和三联抗血小板治疗中,再梗死的发生率较低。 PCI指数后的结果特征是再梗塞的重要决定因素。然而,再梗塞与预后不良有关,特别是支架内血栓形成的患者预后不良。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号